Author: Voutsinas D. Foudoulaki L. Sofroniadou K. Galanakis N.
Publisher: Elsevier
ISSN: 0953-6205
Source: European Journal of Internal Medicine, Vol.12, Iss.2, 2001-04, pp. : 127-129
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Miltefosine in visceral leishmaniasis
By Olliaro P.L. Ridley R.G. Engel J. Sindermann H. Bryceson A.D.M.
The Lancet Infectious Diseases, Vol. 3, Iss. 2, 2003-02 ,pp. :
Visceral Leishmaniasis: Advances in Treatment
Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 3, 2008-11 ,pp. :
The African Green Monkey model for cutaneous and visceral leishmaniasis
By Olobo J.O. Gicheru M.M. Anjili C.O.
Trends in Parasitology, Vol. 17, Iss. 12, 2001-12 ,pp. :